Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cisco Systems, Inc. (CSCO)’s Making New Highs, but the Stock’s Still Cheap

Page 1 of 2

I’m not holding my breath for Cisco Systems, Inc. (NASDAQ:CSCO) to return to its robust growth levels of the dot-com era. But with shares making new 52-week highs, it seems that the Street is at least willing to consider that this company is far from a dinosaur. But how well is Cisco’s transition going? While Cisco Systems, Inc. (NASDAQ:CSCO) is sometimes loathed for being “too big,” management has consistently executed to  keep the company relevant in end markets such as software-defined networking, or SDN.

Cisco Systems, Inc. (NASDAQ:CSCO)This is despite the numerous attacks from the likes of F5 Networks, Inc. (NASDAQ:FFIV) and Juniper Networks, Inc. (NYSE:JNPR) . And despite the recent highs, Cisco Systems, Inc. (NASDAQ:CSCO) still looks undervalued. And I don’t think the Street has fully priced the company on its cash-rich growth prospects. In other words, yes, it’s at a 52-week high, but there’s still a lack of conviction.

So far so good, but…
Granted, Cisco didn’t guide expecting an all-star performance. But the company has a history of under-projecting. And it’s still unclear when tech spending is going to fully recover. Plus, enterprise spending has yet to show clear signs that CIOs are ready to loosen those purse strings. To that end, the company has been moving aggressively to establish a presence in areas such as wireless and data center.

These are good businesses. And the new acquisitions such as BroadHop should help strengthen Cisco’s mobile policy control initiatives. But it’s unclear whether Cisco Systems, Inc. (NASDAQ:CSCO) can be as ground-breaking in mobile like Aruba Networks (NASDAQ:ARUN) or catch fire like Palo Alto Networks Inc (NYSE:PANW) in security. That’s not to suggest that Cisco’s core routing and switching businesses have become chopped liver. But they are not the pillars of the company that they used to be.

In the recent quarter, switch revenue grew 3% year over year, while routing revenue shed more than 5%. This followed a soft first-quarter, when both dropped 2% sequentially and 3% year over year. For that matter, the routing business, which now comprises of 16.1% of Cisco’s total revenue, shed more than 1% sequentially. This means routing is now 1% less of a focus in Cisco’s business. And I think that’s how management wants it.

Plus, it’s clear that Cisco is transitioning from hardware. Or at the very least, the company is looking to offset that focus by deploying new resources toward software. And I think the company’s making good progress. But the Street still seems unsure. This is the only way I can define why both Juniper and F5 trade at price-to-earnings ratios that are more than four times and twice the valuation of Cisco Systems, Inc. (NASDAQ:CSCO). This is despite Cisco’s market lead. It’s as if the Street is saying, “You’re no longer a laggard, but you’re in the wrong markets.”

Better results will propel the shares higher
While Cisco does not post the double-digit growth of F5 Networks, Inc. (NASDAQ:FFIV) or Riverbed Technology, Inc. (NASDAQ:RVBD) , this company seems more serious about the bottom line and just posting consistent results. On the other hand, neither company can match Cisco’s cash flow and returns on capital. And I think Cisco understands this, even though that seems to escape investors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!